WILMINGTON, MASSACHUSETTS--(Marketwire - April 21, 2008) - DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), announced today that the role of D. Geoffrey Shulman, MD, Chairman of the Board and Chief Strategic Officer, is expected to change as a result of a serious health condition. Dr. Shulman expects to be on short term disability to commence in June 2008.
